‘Benetalk’ device study

A company called Respira are looking for participants aged 18-60 to take part in a study with the University of Reading to test its prototype device called Benetalk.

Background and purpose

The device aims to help with learning a speech technique, give nudges to keep practising and provide emotional support. It can be used in challenging speaking situations and communicates with an app to track breathing, speaking and pausing behaviours. 

Respira are carrying out a clinical study with the University of Reading from January 2020 to test whether the device makes a difference to learning and maintaining new speaking habits.

What will it involve?

The study will last 8 months. All participants will receive a full course of the Camperdown Program, a fluency shaping method. Half of the participants will wear the device for the course of the study. They can keep the device after the study.

The speech therapy will be delivered via videoconference to groups of 5 participants. Each group will receive two 1-hour therapy sessions per week for 10 weeks, so each participant receives 20 hours of direct speech and language therapy group sessions. The participants will not interact with the Speech and Language Therapist for the remaining 26 weeks of the study but the experimental group will continue wearing the device.

Who can take part?

The researchers are looking for people who stammer aged 18 to 60 with a good level of English proficiency.

Where is it?

All assessments, therapy sessions and follow-up will be carried out remotely via email and videoconferencing.

When is it?

The study starts on the 6th January 2020 and runs until the 16th September 2020.


If you would like to participate or have any other queries, contact Christiane Dehnhardt by emailing christiane@respira.io

For more information about the device, go to www.BeneTalk.com

University of Reading logo

Become a member. Connect with others locally and online. Volunteer, donate and share your story to inspire others. Everyone is welcome.